A federal transvaginal mesh lawsuit against C.R. Bard has resumed in West Virginia. New jurors were selected after a judge decided that the former jury would not be able to be impartial in reaching a verdict against the mesh manufacturer.
The West Virginia surgical mesh trial is the first federal lawsuit to be heard in court, with more than 4,000 transvaginal mesh side effects lawsuits pending against C. R. Bard alone. The judge will hear four primary lawsuits which may help determine the outcome of some of the other 4,000 against the company.
The transvaginal mesh patch was approved by the Food and Drug Administration in 2002, but the FDA issued an update in 2011 stating that it was wrong in its initial assessment that the product was safe. Women have complained of severe transvaginal mesh complications, including tissue damage, mesh migration and organ perforation.